Trimodality Therapy in the Treatment of Stage III N2‐Positive Non‐Small Cell Lung Cancer: A National Cancer Database Analysis

BACKGROUND: Significant controversy remains regarding the care of patients with clinical stage III (N2‐positive) NSCLC. Although multimodality therapy is effective, the roles of surgery, chemotherapy, and radiotherapy are not fully defined and the optimal treatment approach is not firmly established...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Oncologist
Main Authors: Behera, Madhusmita, Steuer, Conor E., Liu, Yuan, Fernandez, Felix, Fu, Chao, Higgins, Kristin A., Gillespie, Theresa W., Pakkala, Suchita, Pillai, Rathi N., Force, Seth, Belani, Chandra P., Khuri, Fadlo R., Curran, Walter J., Ramalingam, Suresh S.
Format: Artigo
Jezik:Inglês
Izdano: John Wiley & Sons, Inc. 2020
Teme:
Lung Cancer
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7288644/
https://ncbi.nlm.nih.gov/pubmed/31943520
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0661
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki